Does show why we would have preferred it kept in house. Realistically 15%+ value given up in the float.Decision now comes down to waiting for Chin's next deal or moving on.
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025